Ribocure Pharmaceuticals

Ribocure Pharmaceuticals AB Operating as a subsidiary of Ribo Life Science Co., Ltd.,Ribocure Pharmaceuticals AB is a newly established Swedish biotech company with a business focus on the development of cutting-edge RNA therapeutics. Ribocure’s primary focus lies in addressing the significant medical gaps in rare diseases involved in the fields of cardiovascular, renal, and oncology. The company is dedicated to the discovery and development of groundbreaking drug assets utilizing advanced oligonucleotide technologies.